Literature DB >> 24899548

Amorfrutins: A promising class of natural products that are beneficial to health.

Sascha Sauer1.   

Abstract

The incidence of complex noncommunicable diseases has strongly increased over the last several decades in the US, Europe and other parts of the world that have adopted a western lifestyle (M. Ezzati, E. Riboli, Science- 2012, 337, 1482-1487; S. Smyth, A. Heron, Nat. Med.- 2006, 12, 75). Despite considerable investment in the development of new types of drugs, options for the treatment of many common diseases remain inadequate. If current trends prevail, the rising incidence of disorders such as obesity and type 2 diabetes mellitus (T2DM) will soon result in an unsustainable burden on society (World Health Organization Technical Report Series- 2000, 894, i-xii, 1-253). Given the difficulty of treating fully developed complex disorders, new strategies for early intervention and prevention of common diseases are of great interest. Dietary natural products with beneficial effects, such as the recently described antidiabetic and lipid-lowering amorfrutins, could pave the way for efficiently treating and preventing metabolic and other complex diseases (C. Weidner, et al. Proc. Natl. Acad. Sci. USA- 2012, 109, 7257-7262).
© 2014 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  gene expression; ligand effects; metabolic diseases; nutraceuticals; receptors

Mesh:

Substances:

Year:  2014        PMID: 24899548     DOI: 10.1002/cbic.201402124

Source DB:  PubMed          Journal:  Chembiochem        ISSN: 1439-4227            Impact factor:   3.164


  7 in total

1.  Neutral Loss Scan - Based Strategy for Integrated Identification of Amorfrutin Derivatives, New Peroxisome Proliferator-Activated Receptor Gamma Agonists, from Amorpha Fruticosa by UPLC-QqQ-MS/MS and UPLC-Q-TOF-MS.

Authors:  Chu Chen; Ying Xue; Qing-Miao Li; Yan Wu; Jian Liang; Lin-Sen Qing
Journal:  J Am Soc Mass Spectrom       Date:  2018-02-05       Impact factor: 3.109

2.  A Study on the Safety and Effects of Amorpha fruticosa Fruit Extract on Spontaneously Hypertensive Rats with Induced Type 2 Diabetes.

Authors:  Rumyana Simeonova; Aleksandar Shkondrov; Ekaterina Kozuharova; Iliana Ionkova; Ilina Krasteva
Journal:  Curr Issues Mol Biol       Date:  2022-06-02       Impact factor: 2.976

Review 3.  Mass Spectrometry-Based Metabolomics of Phytocannabinoids from Non-Cannabis Plant Origins.

Authors:  Sarana Rose Sommano; Piyachat Sunanta; Noppol Leksawasdi; Kittisak Jantanasakulwong; Pornchai Rachtanapun; Phisit Seesuriyachan; Yuthana Phimolsiripol; Korawan Sringarm; Warintorn Ruksiriwanich; Pensak Jantrawut; Chuda Chittasupho
Journal:  Molecules       Date:  2022-05-20       Impact factor: 4.927

4.  Syntheses of Amorfrutins and Derivatives via Tandem Diels-Alder and Anionic Cascade Approaches.

Authors:  Brian J Curtis; Robert J Micikas; Russell N Burkhardt; Rubin A Smith; Judy Y Pan; Katrina Jander; Frank C Schroeder
Journal:  J Org Chem       Date:  2021-03-04       Impact factor: 4.198

Review 5.  Structure-Activity Relationship of Cannabis Derived Compounds for the Treatment of Neuronal Activity-Related Diseases.

Authors:  Cristina Prandi; Marco Blangetti; Dvora Namdar; Hinanit Koltai
Journal:  Molecules       Date:  2018-06-25       Impact factor: 4.411

6.  Amorphigenin from Amorpha fruticosa L. Root Extract Induces Autophagy-Mediated Melanosome Degradation in mTOR-Independent- and AMPK-Dependent Manner.

Authors:  Ki Won Lee; Dang Thi Nguyen; Minju Kim; Si Hyeon Lee; Seyeon Lim; Jisu Kim; Ki Hun Park; Jeong Yoon Kim; Jiyun Yoo; Cheol Hwangbo; Kwang Dong Kim
Journal:  Curr Issues Mol Biol       Date:  2022-06-29       Impact factor: 2.976

7.  Analysis of bioactive constituents from the leaves of Amorpha fruticosa L.

Authors:  Xueqin Cui; Jing Guo; Ching-Shu Lai; Min-Hsiung Pan; Zhongxiao Ma; Sen Guo; Qingchao Liu; Li Zhang; Chi-Tang Ho; Naisheng Bai
Journal:  J Food Drug Anal       Date:  2016-12-01       Impact factor: 6.157

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.